ZL-1310 shows promising activity in DLL3-positive neuroendocrine carcinomas

DLL3 expression in circulating tumour cells predicts response to tarlatamab in small cell lung cancer

Development and challenges for T-cell engagers as a novel treatment for lung cancer and mesothelioma

TQB2922 combination shows high response rates in EGFR-mutant lung cancer after tyrosine kinase inhibitor resistance

Artificial intelligence PD-L1 scoring matches pathologists and improves reproducibility in lung cancer testing

Cracking the code: Bispecific immunotherapy in small cell lung cancer

Rituximab-based chemotherapy achieves strong outcomes without routine radiotherapy in stage I extranodal large B-cell lymphoma

Durvalumab plus chemotherapy improves outcomes and urine tumour DNA predicts response in muscle-invasive bladder cancer

Zolbetuximab plus nivolumab and chemotherapy shows promising responses in CLDN18.2-positive metastatic gastric cancer

EAU 2026: Updates in NMIBC

Circulating tumour DNA shows high accuracy for monitoring testicular cancer across all stages

Pembrolizumab plus belzutifan improves disease-free survival in high-risk kidney cancer after surgery